Literature DB >> 12072077

Reliability testing of the Six Area, Six Sign Atopic Dermatitis severity score.

C R Charman1, A J Venn, H C Williams.   

Abstract

BACKGROUND: The Six Area, Six Sign Atopic Dermatitis (SASSAD) severity score is an objective atopic eczema severity index designed principally to assess response to treatment in therapeutic trials. Validity has been demonstrated in single and multicentre clinical trials, although data on the reliability of the index have not previously been published.
OBJECTIVES: To assess inter- and intraobserver variability of the SASSAD index.
METHODS: Six observers with experience in the assessment of atopic eczema were each asked to score disease severity in six patients with moderate to severe atopic eczema using the SASSAD index. Repeat observations were carried out on randomly selected patients by each observer to estimate intraobserver variation.
RESULTS: The interobserver variation in total SASSAD scores for each patient ranged from 7 to 30 (median 15.5) out of a maximum possible score of 108. The intraclass correlation coefficient ri for the total scores among all six observers was quite high at 0.70, although interobserver agreement for individual components of the index was poor to moderate. The maximum recorded intraobserver variation in total SASSAD score in any of the examined patients was 8 units.
CONCLUSIONS: As with many other tested atopic eczema scoring indices, the SASSAD index is subject to significant interobserver variation, reflecting the difficulties in reliably assessing eczema severity objectively.

Entities:  

Mesh:

Year:  2002        PMID: 12072077     DOI: 10.1046/j.1365-2133.2002.04644.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  11 in total

1.  Predicting eczema severity beyond childhood.

Authors:  Kam Lun Hon; Yin-Ching K Tsang; Terence Chuen W Poon; Nga Hin Pong; Matthew Kwan; Shirley Lau; Yuen-Chun Chiu; Hin-Hei Wong; Ting-Fan Leung
Journal:  World J Pediatr       Date:  2015-12-18       Impact factor: 2.764

Review 2.  Phototherapy for atopic eczema.

Authors:  Annelie H Musters; Soudeh Mashayekhi; Jane Harvey; Emma Axon; Stephanie J Lax; Carsten Flohr; Aaron M Drucker; Louise Gerbens; John Ferguson; Sally Ibbotson; Robert S Dawe; Floor Garritsen; Marijke Brouwer; Jacqueline Limpens; Laura E Prescott; Robert J Boyle; Phyllis I Spuls
Journal:  Cochrane Database Syst Rev       Date:  2021-10-28

3.  The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures.

Authors:  Thaschawee Arkachaisri; Soamarat Vilaiyuk; Suzanne Li; Kathleen M O'Neil; Elena Pope; Gloria C Higgins; Marilynn Punaro; Egla C Rabinovich; Margalit Rosenkranz; Daniel A Kietz; Paul Rosen; Steven J Spalding; Teresa R Hennon; Kathryn S Torok; Elaine Cassidy; Thomas A Medsger
Journal:  J Rheumatol       Date:  2009-10-15       Impact factor: 4.666

Review 4.  Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.

Authors:  Lawrence F Eichenfield; Wynnis L Tom; Sarah L Chamlin; Steven R Feldman; Jon M Hanifin; Eric L Simpson; Timothy G Berger; James N Bergman; David E Cohen; Kevin D Cooper; Kelly M Cordoro; Dawn M Davis; Alfons Krol; David J Margolis; Amy S Paller; Kathryn Schwarzenberger; Robert A Silverman; Hywel C Williams; Craig A Elmets; Julie Block; Christopher G Harrod; Wendy Smith Begolka; Robert Sidbury
Journal:  J Am Acad Dermatol       Date:  2013-11-27       Impact factor: 11.527

Review 5.  Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010.

Authors:  Balvinder Rehal; April W Armstrong; April Armstrong
Journal:  PLoS One       Date:  2011-04-13       Impact factor: 3.240

6.  Food allergen sensitization pattern in adults in relation to severity of atopic dermatitis.

Authors:  Heike Röckmann; Maartje J van Geel; Andre C Knulst; Jorike Huiskes; Carla Afm Bruijnzeel-Koomen; Marjolein S de Bruin-Weller
Journal:  Clin Transl Allergy       Date:  2014-03-28       Impact factor: 5.871

7.  Systemic treatments for eczema: a network meta-analysis.

Authors:  Ratree Sawangjit; Piyameth Dilokthornsakul; Antonia Lloyd-Lavery; Nai Ming Lai; Robert Dellavalle; Nathorn Chaiyakunapruk
Journal:  Cochrane Database Syst Rev       Date:  2020-09-14

8.  New Developments in Biomarkers for Atopic Dermatitis.

Authors:  Judith L Thijs; Wouter van Seggelen; Carla Bruijnzeel-Koomen; Marjolein de Bruin-Weller; DirkJan Hijnen
Journal:  J Clin Med       Date:  2015-03-16       Impact factor: 4.241

9.  Hyper IgE in Childhood Eczema and Risk of Asthma in Chinese Children.

Authors:  Chantel Ng; Kam Lun Hon; Jeng Sum Charmaine Kung; Nga Hin Pong; Ting-Fan Leung; Chun Kwok Wong
Journal:  Molecules       Date:  2016-06-10       Impact factor: 4.411

10.  Differences in Psychometric Properties of Clinician- and Patient-Reported Outcome Measures for Atopic Dermatitis by Race and Skin Tone: A Systematic Review.

Authors:  Trisha Kaundinya; Uros Rakita; Armaan Guraya; Donna Maria Abboud; Emily Croce; Jacob P Thyssen; Andrew Alexis; Jonathan I Silverberg
Journal:  J Invest Dermatol       Date:  2021-08-02       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.